Weihua Li

机构：Fudan University, Shanghai Institute of Pharmaceutical Industry · ORCID：0000-0003-4596-9088

发表论文 54 篇 · 总被引 1601 次 · h-index 20

代表论文

• The reservoir of latent HIV (2022 · Frontiers in Cellular and Infection Microbiology · 被引 98)
• Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains (2018 · International Journal of Molecular Sciences · 被引 71)
• Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases (2020 · International Journal of Molecular Sciences · 被引 49)
• Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern (2022 · Trends in Immunology · 被引 38)
• Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling (2018 · International Immunopharmacology · 被引 36)
• Flurochloridone induces Sertoli cell apoptosis through ROS-dependent mitochondrial pathway (2021 · Ecotoxicology and Environmental Safety · 被引 35)